| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.38B | -19.1% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 10.2% | Net margin -1.8% |
| Revenue Q/Q | -22.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.34B | 89.8% |
| R&D | ¥0.01B | 3.6% |
| SG&A | ¥0.03B | 7.5% |
| Tax & other | ¥-0.00B | -0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
百胜智能 ・ 亚康股份 ・ 鸿富瀚 ・ 可孚医疗 ・ 戎美股份 ・ 拓新药业 ・ 华润材料 ・ 深城交 ・ 争光股份 ・ 华兰股份 ・ 广立微 ・ 百诚医药
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies